Concepts (220)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Adipose Tissue | 13 | 2020 | 349 | 1.990 |
Why?
|
| Pericardium | 9 | 2019 | 52 | 1.910 |
Why?
|
| Calcinosis | 4 | 2013 | 146 | 1.070 |
Why?
|
| Atherosclerosis | 11 | 2020 | 766 | 0.980 |
Why?
|
| Diabetes Mellitus, Type 2 | 7 | 2019 | 1428 | 0.840 |
Why?
|
| Ethnic Groups | 3 | 2020 | 476 | 0.770 |
Why?
|
| Coronary Artery Disease | 4 | 2013 | 401 | 0.660 |
Why?
|
| Aging | 7 | 2020 | 946 | 0.610 |
Why?
|
| Aged | 33 | 2020 | 10314 | 0.600 |
Why?
|
| Cardiovascular Diseases | 7 | 2019 | 1128 | 0.580 |
Why?
|
| Cognition | 3 | 2020 | 556 | 0.570 |
Why?
|
| Obesity | 7 | 2020 | 1176 | 0.570 |
Why?
|
| Aged, 80 and over | 19 | 2019 | 3990 | 0.570 |
Why?
|
| Lipids | 4 | 2019 | 232 | 0.550 |
Why?
|
| Body Composition | 6 | 2019 | 397 | 0.510 |
Why?
|
| Cholesterol | 2 | 2019 | 252 | 0.490 |
Why?
|
| Female | 37 | 2020 | 20016 | 0.480 |
Why?
|
| Diabetic Retinopathy | 1 | 2014 | 65 | 0.460 |
Why?
|
| Monocytes | 4 | 2017 | 127 | 0.460 |
Why?
|
| Male | 35 | 2020 | 19218 | 0.460 |
Why?
|
| Genome-Wide Association Study | 9 | 2020 | 547 | 0.460 |
Why?
|
| Body Mass Index | 7 | 2010 | 923 | 0.450 |
Why?
|
| Middle Aged | 27 | 2020 | 11839 | 0.450 |
Why?
|
| Coronary Vessels | 3 | 2013 | 165 | 0.440 |
Why?
|
| Genetic Predisposition to Disease | 3 | 2020 | 835 | 0.440 |
Why?
|
| European Continental Ancestry Group | 6 | 2020 | 1166 | 0.430 |
Why?
|
| DNA Methylation | 5 | 2019 | 141 | 0.430 |
Why?
|
| Coronary Circulation | 2 | 2011 | 43 | 0.410 |
Why?
|
| Risk Factors | 16 | 2019 | 3880 | 0.400 |
Why?
|
| Humans | 40 | 2020 | 32115 | 0.390 |
Why?
|
| Cognition Disorders | 1 | 2014 | 385 | 0.380 |
Why?
|
| Myocardium | 1 | 2011 | 186 | 0.370 |
Why?
|
| Severity of Illness Index | 2 | 2013 | 881 | 0.360 |
Why?
|
| Cohort Studies | 9 | 2019 | 1817 | 0.350 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2014 | 1328 | 0.340 |
Why?
|
| Asian Continental Ancestry Group | 3 | 2020 | 108 | 0.330 |
Why?
|
| Tomography, X-Ray Computed | 8 | 2019 | 919 | 0.320 |
Why?
|
| Coronary Stenosis | 1 | 2008 | 30 | 0.320 |
Why?
|
| Coronary Disease | 1 | 2009 | 211 | 0.300 |
Why?
|
| Cardiomyopathies | 1 | 2008 | 56 | 0.300 |
Why?
|
| Stroke | 2 | 2017 | 585 | 0.290 |
Why?
|
| Plasminogen Activator Inhibitor 1 | 1 | 2006 | 44 | 0.280 |
Why?
|
| Haplotypes | 1 | 2006 | 220 | 0.270 |
Why?
|
| Cross-Sectional Studies | 5 | 2019 | 1542 | 0.270 |
Why?
|
| Polymorphism, Single Nucleotide | 6 | 2020 | 1062 | 0.270 |
Why?
|
| Polymorphism, Genetic | 1 | 2006 | 184 | 0.260 |
Why?
|
| African Continental Ancestry Group | 4 | 2019 | 363 | 0.240 |
Why?
|
| Asian Americans | 2 | 2019 | 97 | 0.240 |
Why?
|
| Adult | 10 | 2019 | 9381 | 0.230 |
Why?
|
| Hypertension | 3 | 2017 | 960 | 0.210 |
Why?
|
| Transcription Factors | 3 | 2019 | 181 | 0.210 |
Why?
|
| Myocardial Infarction | 1 | 2006 | 475 | 0.210 |
Why?
|
| Depression | 2 | 2018 | 445 | 0.200 |
Why?
|
| Genetic Loci | 2 | 2019 | 146 | 0.190 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 1 | 2020 | 17 | 0.190 |
Why?
|
| Multifactorial Inheritance | 1 | 2020 | 21 | 0.180 |
Why?
|
| Mutation, Missense | 1 | 2020 | 50 | 0.180 |
Why?
|
| Metformin | 1 | 2020 | 22 | 0.180 |
Why?
|
| Incidence | 7 | 2020 | 1199 | 0.180 |
Why?
|
| Coronary Angiography | 2 | 2013 | 153 | 0.180 |
Why?
|
| Muscular Atrophy | 2 | 2012 | 71 | 0.180 |
Why?
|
| Fibroblast Growth Factors | 1 | 2019 | 35 | 0.170 |
Why?
|
| Fats | 1 | 2019 | 2 | 0.170 |
Why?
|
| Hypoglycemic Agents | 1 | 2020 | 181 | 0.160 |
Why?
|
| Inflammation | 3 | 2020 | 530 | 0.160 |
Why?
|
| Heart Failure | 2 | 2020 | 639 | 0.160 |
Why?
|
| Gene Expression | 2 | 2017 | 338 | 0.140 |
Why?
|
| Brain | 2 | 2014 | 951 | 0.140 |
Why?
|
| DNA-Binding Proteins | 1 | 2017 | 147 | 0.140 |
Why?
|
| Carrier Proteins | 1 | 2017 | 136 | 0.140 |
Why?
|
| Alcohol Drinking | 1 | 2019 | 255 | 0.140 |
Why?
|
| Liver | 1 | 2019 | 484 | 0.130 |
Why?
|
| Gene Dosage | 1 | 2015 | 35 | 0.130 |
Why?
|
| Gene Expression Regulation | 2 | 2015 | 495 | 0.130 |
Why?
|
| Waist Circumference | 3 | 2010 | 90 | 0.130 |
Why?
|
| Exercise | 2 | 2019 | 673 | 0.130 |
Why?
|
| Sex Factors | 2 | 2017 | 667 | 0.120 |
Why?
|
| Smoking | 1 | 2019 | 528 | 0.120 |
Why?
|
| Linear Models | 4 | 2010 | 449 | 0.120 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2014 | 55 | 0.120 |
Why?
|
| Aorta, Thoracic | 2 | 2013 | 85 | 0.120 |
Why?
|
| Aortic Diseases | 2 | 2013 | 63 | 0.120 |
Why?
|
| Longitudinal Studies | 2 | 2014 | 770 | 0.120 |
Why?
|
| Intra-Abdominal Fat | 2 | 2011 | 63 | 0.120 |
Why?
|
| Weight Loss | 2 | 2015 | 480 | 0.120 |
Why?
|
| Phenotype | 3 | 2020 | 632 | 0.120 |
Why?
|
| Blood Pressure | 2 | 2017 | 846 | 0.110 |
Why?
|
| Aortography | 1 | 2013 | 16 | 0.110 |
Why?
|
| Hypercholesterolemia | 1 | 2014 | 70 | 0.110 |
Why?
|
| Genotype | 3 | 2019 | 733 | 0.110 |
Why?
|
| Neuropsychological Tests | 1 | 2014 | 371 | 0.110 |
Why?
|
| Pharyngeal Muscles | 1 | 2012 | 5 | 0.110 |
Why?
|
| Deglutition | 1 | 2012 | 29 | 0.100 |
Why?
|
| Perfusion | 1 | 2011 | 73 | 0.100 |
Why?
|
| Prospective Studies | 5 | 2013 | 2284 | 0.100 |
Why?
|
| African Americans | 2 | 2010 | 1425 | 0.100 |
Why?
|
| Hemodynamics | 1 | 2011 | 155 | 0.090 |
Why?
|
| Health Status | 1 | 2013 | 400 | 0.090 |
Why?
|
| Epigenesis, Genetic | 3 | 2017 | 104 | 0.090 |
Why?
|
| Abdominal Fat | 1 | 2010 | 50 | 0.090 |
Why?
|
| Prognosis | 1 | 2014 | 1497 | 0.090 |
Why?
|
| Tunica Media | 1 | 2010 | 28 | 0.090 |
Why?
|
| Multivariate Analysis | 1 | 2011 | 684 | 0.090 |
Why?
|
| Tunica Intima | 1 | 2010 | 57 | 0.090 |
Why?
|
| Caloric Restriction | 1 | 2011 | 106 | 0.090 |
Why?
|
| Carotid Artery, Common | 1 | 2010 | 39 | 0.090 |
Why?
|
| Heart Atria | 1 | 2010 | 65 | 0.090 |
Why?
|
| Carotid Artery, Internal | 1 | 2010 | 32 | 0.090 |
Why?
|
| Risk Assessment | 3 | 2013 | 1429 | 0.090 |
Why?
|
| C-Reactive Protein | 2 | 2017 | 238 | 0.080 |
Why?
|
| Cerebrovascular Disorders | 1 | 2010 | 52 | 0.080 |
Why?
|
| Proportional Hazards Models | 2 | 2013 | 753 | 0.080 |
Why?
|
| Postmenopause | 1 | 2011 | 430 | 0.080 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 1 | 2008 | 38 | 0.080 |
Why?
|
| Cholesterol, HDL | 2 | 2019 | 177 | 0.080 |
Why?
|
| Waist-Hip Ratio | 1 | 2008 | 34 | 0.080 |
Why?
|
| Cholesterol, LDL | 2 | 2019 | 173 | 0.080 |
Why?
|
| Triglycerides | 2 | 2019 | 230 | 0.080 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2008 | 132 | 0.080 |
Why?
|
| Hispanic Americans | 2 | 2019 | 940 | 0.080 |
Why?
|
| Health Surveys | 1 | 2008 | 198 | 0.070 |
Why?
|
| Young Adult | 3 | 2019 | 2666 | 0.070 |
Why?
|
| Dietary Proteins | 1 | 2008 | 55 | 0.070 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2008 | 170 | 0.070 |
Why?
|
| Mobility Limitation | 1 | 2009 | 219 | 0.070 |
Why?
|
| Body Size | 1 | 2007 | 34 | 0.070 |
Why?
|
| Overweight | 1 | 2009 | 280 | 0.070 |
Why?
|
| Case-Control Studies | 1 | 2009 | 898 | 0.070 |
Why?
|
| Life Style | 2 | 2019 | 408 | 0.070 |
Why?
|
| Adolescent | 3 | 2019 | 3569 | 0.070 |
Why?
|
| Continental Population Groups | 2 | 2019 | 237 | 0.070 |
Why?
|
| Skin | 1 | 2008 | 211 | 0.070 |
Why?
|
| Kidney | 1 | 2010 | 518 | 0.070 |
Why?
|
| Alleles | 1 | 2006 | 248 | 0.070 |
Why?
|
| Promoter Regions, Genetic | 1 | 2006 | 208 | 0.070 |
Why?
|
| Adiposity | 3 | 2011 | 198 | 0.060 |
Why?
|
| Organ Size | 2 | 2019 | 218 | 0.060 |
Why?
|
| CpG Islands | 2 | 2015 | 45 | 0.060 |
Why?
|
| United States | 4 | 2019 | 3976 | 0.060 |
Why?
|
| Gene Expression Profiling | 2 | 2017 | 322 | 0.060 |
Why?
|
| Muscle, Skeletal | 1 | 2008 | 519 | 0.050 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2003 | 210 | 0.050 |
Why?
|
| Interleukin-6 | 1 | 2003 | 247 | 0.050 |
Why?
|
| Age Factors | 3 | 2011 | 1189 | 0.050 |
Why?
|
| Genetics | 1 | 2020 | 4 | 0.050 |
Why?
|
| Interleukin-7 | 1 | 2020 | 10 | 0.050 |
Why?
|
| Goblet Cells | 1 | 2020 | 5 | 0.050 |
Why?
|
| Hematopoiesis | 1 | 2020 | 33 | 0.050 |
Why?
|
| Mucins | 1 | 2020 | 18 | 0.050 |
Why?
|
| Gene Regulatory Networks | 1 | 2020 | 41 | 0.050 |
Why?
|
| Disease Susceptibility | 1 | 2019 | 57 | 0.040 |
Why?
|
| Vascular Endothelial Growth Factor B | 1 | 2019 | 5 | 0.040 |
Why?
|
| Asia | 1 | 2019 | 19 | 0.040 |
Why?
|
| Antihypertensive Agents | 2 | 2014 | 352 | 0.040 |
Why?
|
| Brazil | 1 | 2019 | 16 | 0.040 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2019 | 35 | 0.040 |
Why?
|
| Calcium-Binding Proteins | 1 | 2019 | 45 | 0.040 |
Why?
|
| Muscle Proteins | 1 | 2019 | 59 | 0.040 |
Why?
|
| Linkage Disequilibrium | 1 | 2019 | 185 | 0.040 |
Why?
|
| Lipid Metabolism | 1 | 2019 | 105 | 0.040 |
Why?
|
| Prediabetic State | 1 | 2019 | 65 | 0.040 |
Why?
|
| Nerve Tissue Proteins | 1 | 2019 | 120 | 0.040 |
Why?
|
| CCAAT-Enhancer-Binding Proteins | 1 | 2017 | 9 | 0.040 |
Why?
|
| Poly(ADP-ribose) Polymerases | 1 | 2017 | 10 | 0.040 |
Why?
|
| Stroke Volume | 1 | 2020 | 348 | 0.040 |
Why?
|
| Hospitalization | 1 | 2020 | 470 | 0.040 |
Why?
|
| Histones | 1 | 2017 | 53 | 0.040 |
Why?
|
| Membrane Proteins | 1 | 2019 | 256 | 0.040 |
Why?
|
| Lysine | 1 | 2017 | 23 | 0.040 |
Why?
|
| Blood Pressure Determination | 1 | 2017 | 100 | 0.040 |
Why?
|
| Absorptiometry, Photon | 2 | 2008 | 143 | 0.030 |
Why?
|
| Predictive Value of Tests | 2 | 2013 | 876 | 0.030 |
Why?
|
| North Carolina | 2 | 2011 | 1538 | 0.030 |
Why?
|
| Disease Models, Animal | 1 | 2020 | 1022 | 0.030 |
Why?
|
| Prevalence | 1 | 2019 | 989 | 0.030 |
Why?
|
| Ribosomes | 1 | 2015 | 10 | 0.030 |
Why?
|
| Oxidative Phosphorylation | 1 | 2015 | 23 | 0.030 |
Why?
|
| Protein Biosynthesis | 1 | 2015 | 40 | 0.030 |
Why?
|
| Autophagy | 1 | 2015 | 52 | 0.030 |
Why?
|
| Heart Rate | 1 | 2017 | 335 | 0.030 |
Why?
|
| T-Lymphocytes | 1 | 2015 | 124 | 0.030 |
Why?
|
| Mice | 1 | 2020 | 2484 | 0.030 |
Why?
|
| Genome, Human | 1 | 2014 | 132 | 0.030 |
Why?
|
| Transcription Initiation Site | 1 | 2013 | 10 | 0.030 |
Why?
|
| Glutathione Transferase | 1 | 2013 | 13 | 0.030 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2013 | 24 | 0.030 |
Why?
|
| Discriminant Analysis | 1 | 2013 | 21 | 0.030 |
Why?
|
| Heart Valve Diseases | 1 | 2013 | 27 | 0.030 |
Why?
|
| Area Under Curve | 1 | 2013 | 93 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 5 | 1 | 2013 | 15 | 0.030 |
Why?
|
| Velopharyngeal Sphincter | 1 | 2012 | 4 | 0.030 |
Why?
|
| Aortic Valve | 1 | 2013 | 49 | 0.030 |
Why?
|
| ROC Curve | 1 | 2013 | 164 | 0.030 |
Why?
|
| Mitral Valve | 1 | 2013 | 32 | 0.030 |
Why?
|
| Chi-Square Distribution | 1 | 2013 | 297 | 0.030 |
Why?
|
| Cause of Death | 1 | 2013 | 236 | 0.030 |
Why?
|
| Head | 1 | 2012 | 51 | 0.030 |
Why?
|
| Deglutition Disorders | 1 | 2012 | 51 | 0.030 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2014 | 145 | 0.030 |
Why?
|
| Subcutaneous Fat, Abdominal | 1 | 2011 | 15 | 0.020 |
Why?
|
| Radiography | 1 | 2012 | 376 | 0.020 |
Why?
|
| Magnetic Resonance Angiography | 1 | 2011 | 77 | 0.020 |
Why?
|
| Oxygen Consumption | 1 | 2011 | 154 | 0.020 |
Why?
|
| Aorta | 1 | 2010 | 126 | 0.020 |
Why?
|
| Follow-Up Studies | 2 | 2006 | 2265 | 0.020 |
Why?
|
| Confidence Intervals | 1 | 2009 | 149 | 0.020 |
Why?
|
| Age Distribution | 1 | 2009 | 206 | 0.020 |
Why?
|
| Statistics as Topic | 1 | 2008 | 108 | 0.020 |
Why?
|
| Animals | 1 | 2020 | 7542 | 0.020 |
Why?
|
| Meat | 1 | 2008 | 15 | 0.020 |
Why?
|
| Contrast Media | 1 | 2008 | 138 | 0.020 |
Why?
|
| Time Factors | 1 | 2013 | 2151 | 0.020 |
Why?
|
| Nutrition Assessment | 1 | 2008 | 55 | 0.020 |
Why?
|
| Ultrasonography | 1 | 2010 | 379 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2008 | 582 | 0.020 |
Why?
|
| Comorbidity | 1 | 2008 | 566 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2008 | 765 | 0.020 |
Why?
|
| Body Fat Distribution | 1 | 2006 | 34 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2014 | 3306 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2012 | 3510 | 0.010 |
Why?
|